ACADIA Pharmaceuticals: Q1 Earnings Insights

ACADIA Pharmaceuticals ACAD reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

ACADIA Pharmaceuticals missed estimated earnings by 16.67%, reporting an EPS of $-0.7 versus an estimate of $-0.6.

Revenue was up $8.91 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.03 which was followed by a 1.34% drop in the share price the next day.

Here's a look at ACADIA Pharmaceuticals's past performance:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.24 -0.26 -0.31 -0.53
EPS Actual -0.27 -0.09 -0.27 -0.42
Revenue Estimate 135.60M 127.75M 126.15M 111.63M
Revenue Actual 130.76M 131.61M 115.22M 106.55M

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.24 -0.26 -0.31 -0.53
EPS Actual -0.27 -0.09 -0.27 -0.42
Revenue Estimate 135.60M 127.75M 126.15M 111.63M
Revenue Actual 130.76M 131.61M 115.22M 106.55M

To track all earnings releases for ACADIA Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarnings